Single-cell analyses have emerged as powerful tools for studying cellular heterogeneity and gene regulation. Single-cell chromatin accessibility ...
Quesma, Inc. announced the release of OTelBench, the first comprehensive benchmark for evaluating LLMs on OpenTelemetry instrumentation tasks, revealing significant gaps in AI's ability to handle ...
Shattering the myths that hold you back from shifting to a better OS.
Given the rapidly evolving landscape of Artificial Intelligence, one of the biggest hurdles tech leaders often come across is ...
The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with neuropathic corneal pain, according to a press release from Okyo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results